These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9869434)

  • 1. The efficacy and safety of aprotinin use in cardiac surgery.
    Rich JB
    Ann Thorac Surg; 1998 Nov; 66(5 Suppl):S6-11; discussion S25-8. PubMed ID: 9869434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
    Lemmer JH; Stanford W; Bonney SL; Breen JF; Chomka EV; Eldredge WJ; Holt WW; Karp RB; Laub GW; Lipton MJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):543-51; discussion 551-3. PubMed ID: 7508070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
    Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
    Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of aprotinin on coronary artery bypass graft patency.
    Laub GW; Riebman JB; Chen C; Adkins MS; Anderson WA; Fernandez J; McGrath LB
    Chest; 1994 Nov; 106(5):1370-5. PubMed ID: 7525162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
    Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
    Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy.
    Lass M; Welz A; Kochs M; Mayer G; Schwandt M; Hannekum A
    Eur J Cardiothorac Surg; 1995; 9(4):206-10. PubMed ID: 7541637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass.
    Berger PB; Alderman EL; Nadel A; Schaff HV
    Circulation; 1999 Dec; 100(23):2353-8. PubMed ID: 10587340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.
    Peters DC; Noble S
    Drugs; 1999 Feb; 57(2):233-60. PubMed ID: 10188764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.
    Davis R; Whittington R
    Drugs; 1995 Jun; 49(6):954-83. PubMed ID: 7543841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results.
    Fraedrich G; Weber C; Bernard C; Hettwer A; Schlosser V
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):89-91. PubMed ID: 2471287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.